(VIANEWS) – Shares of FibroGen (NASDAQ: FGEN) rose 5.07% to $14.52 at 15:15 EST on Tuesday, after three consecutive sessions in a row of gains. NASDAQ is rising 0.63% to $13,855.10, following the last session’s upward trend. This seems, up to now, a somewhat positive trend exchanging session today.

FibroGen’s last close was $14.37, 74.88% under its 52-week high of $57.21.


Today’s last reported volume for FibroGen is 360348 which is 70.19% below its average volume of 1208933.

FibroGen’s Sales

FibroGen’s sales growth is 201.9% for the current quarter and 13.3% for the next. The company’s growth estimates for the ongoing quarter is a negative 134.3% and positive 39.1% for the next.

FibroGen’s Revenue

Year-on-year quarterly revenue growth declined by 43.2%, now sitting on 171.82M for the twelve trailing months.


FibroGen’s last week, last month’s, and last quarter’s current intraday variation average was 1.70%, 0.58%, and 2.75%, respectively.

FibroGen’s highest amplitude of average volatility was 1.85% (last week), 2.78% (last month), and 2.75% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

FibroGen’s stock is considered to be oversold (<=20).

FibroGen’s Stock Yearly Top and Bottom Value

FibroGen’s stock is valued at $14.52 at 15:15 EST, way below its 52-week high of $57.21 and way higher than its 52-week low of $9.88.

FibroGen’s Moving Average

FibroGen’s value is way above its 50-day moving average of $11.90 and way below its 200-day moving average of $18.77.

More news about FibroGen (FGEN).


Please enter your comment!
Please enter your name here